[Skip to Content]
[Skip to Content Landing]
Article
January 1969

Coagulation Defects in Acute Promyelocytic Leukemia

Author Affiliations

Boston

From the Hematology Laboratory and the Circulation Laboratory, Tufts University School of Medicine and Boston City Hospital, Boston. Doctor Rand is currently a Public Health Service trainee in endocrinology and metabolism, Department of Medicine, Flower and Fifth Ave-; nue Hospital, New York. Doctor Moloney is currently with the Department of Medicine, Harvard Medical School, and the Division of Hematology, Peter Bent Brigham Hospital, Boston.

Arch Intern Med. 1969;123(1):39-47. doi:10.1001/archinte.1969.00300110041007
Abstract

Four patients with acute promyelocytic leukemia manifested multiple coagulation abnormalities including hypofibrinogenemia, prolongation of prothrombin and thrombin times, and varying deficiencies of coagulation factors. One of the patients (patient 2) showed rising levels of fibrinogen without changes in other coagulation factors on heparin therapy and demonstrated widespread intravascular coagulation on postmortem examination. Another patient (patient 1) had positive tests for active fibrinolysis and an absolute lack of the usual postmortem thrombi. The current hypotheses of the pathogenesis of the coagulation abnormalities are presented as well as guide to therapeutic management.

References
1.
Boggs, D.R.; Wintrobe, M.M.; and Cartwright, G.E.:  The Acute Leukemias: Analysis of 322 Cases and Review of the Literature ,  Medicine 41:163-225 ( (Sept) ) 1962.Crossref
2.
Bernard, J., et al:  The Very Acute Leukemias ,  Cancer Res 25:1675-1676 ( (Oct) ) 1965.
3.
Risak, E.:  Die Fibrinopenie ,  Z Klin Med 128: 605-629 ( (July) ) 1935.
4.
Hillestad, L.K.:  Acute Promyelocytic Leukemia ,  Acta Med Scand 159:189-194 ( (Aug) ) 1957.Crossref
5.
Croizat, P., and Favre-Gilly, J.:  Les aspects du syndrome hemorrogique des leucemies ,  Sangre 20: 417-421 ( (July) ) 1949.
6.
Giraud, G., et al:  Syndrome hemorrogique mortel par fibrinolyse aigue au cours d'une leucose myeloide ,  Sangre 25:628-633 ( (June) ) 1954.
7.
Cooperberg, A.A., and Neiman, G.M.A.:  Fibrinogenopenia and Fibrinolysis in Acute Myelogenous Leukemia ,  Ann Intern Med 42:706-711 ( (March) ) 1955.Crossref
8.
Pisciotta, A.V., and Schulz, E.J.:  Fibrinolytic Purpura in Acute Leukemia ,  Amer J Med 19:824-828 ( (Nov) ) 1955.Crossref
9.
Rosenthal, R.L.; Lee, S.L.; and Rosenthal, N.:  Hypofibrinogenemia as a Factor in Hemorrhage in Acute Leukemia ,  Clin Res Proc 3:101 ( (May 1) ) 1955.
10.
Stormorken, H.T.:  Fibrinolytic Purpura: Report of a Case of This Affection Accompanying Acute Myelogenous Leukemia ,  Tidsskr Norske Laegefor 76:754-756 ( (Oct) ) 1956.
11.
Bernard, P.J., et al:  La leucose aigue aux promyelocytes ,  Schweiz Med Wchnschr 89:604-608 ( (June) ) 1959.
12.
Hoveid, A.P.:  Acute Promyelocytic Leukemia With Progressive Meningocerebral Involvement During Hematological Remission ,  Nord Med 62: 1521-1523 ( (Oct) ) 1959.
13.
Nilsson, I.M.; Sjoerdsma, A.; and Waldenstrom, J.:  Antifibrinolytic Activity and Metabolism of Epislon Aminocaproic Acid in Man ,  Lancet 1: 1322-1326 ( (June 8) ) 1960.Crossref
14.
Fisher, S.; Ramot, B.; and Kreisler, B.:  Fibrinolysis in Acute Leukemia: A Case Report ,  Israel Med J 19:195-198 ( (July-Aug) ) 1960.
15.
Gingold, V.N.; Vilcu, A.; and Rebedea, D.:  Die promyelozyten Leukamie ,  Z Ges Inn Med 16: 39-41 ( (Jan) ) 1961.
16.
Perugini, S., et al:  Hemorrhagic Syndrome Caused by Fibrinolysis During the Course of Acute Leukemia ,  Schweiz Med Wschr 90:1257 ( (Oct 29) ) 1960.
17.
Rosenthal, R.L.:  Acute Promyelocytic Leukemia Associated With Hypofibrinogenemia ,  Blood 21: 495-508 ( (April) ) 1963.
18.
Ghitis, J.:  Acute Promyelocytic Leukemia ,  Blood 21:237-240 ( (Feb) ) 1963.
19.
Bernard, J., et al:  A Cytological and Histological Study of Acute Promyelocytic Leukemia ,  J Clin Path 16:319-324 ( (July) ) 1963.Crossref
20.
Didisheim, P., et al:  Acute Promyelocytic Leukemia With Fibrinogen and Factor V Deficiency ,  Blood 23:717-728 ( (June) ) 1964.
21.
Verstrate, M., et al:  Excessive Consumption of Blood Coagulation Components as a Cause of Hemorrhagic Diathesis ,  Amer J Med 38:899-908 ( (June) ) 1965.Crossref
22.
Parker, M.G., and Lowney, J.F.:  Acute Promyelocytic Leukemia ,  Missouri Med 62:374-378 ( (May) ) 1965.
23.
Ulutin, O.N., et al:  Acute Promyelocytic Leukemia ,  New Istanbul Contrib Clin Sci 8:65-77 ( (Jan-March) ) 1965.
24.
Ryder, R.J.W.:  Promyelocytic Leukemia and Hypofibrinogenemia ,  Acta Haemat 35:180-191 ( (March) ) 1966.
25.
Bernard, J., et al:  Leucemie aigue à promyelocytes survenue dix-sept ans après un arteriographie carotidienne au thorotrast ,  Presse Med 74:487-490 ( (Feb) ) 1966.
26.
Pittman, G.P.; Senhauser, D.A.; and Lowney, J.F.:  Acute Promyelocytic Leukemia: A Report of Three Autopsied Cases ,  Amer J Clin Path 46:214-220 ( (Aug) ) 1966.
27.
Ben-Zee, D.; Schwartz, S.O.; and Friedman, I.A.:  Promyelocytic-Myelocytic Leukemia as a Terminal Manifestation of Chronic Granulocytic Leukemia ,  Blood 27:863-870 ( (June) ) 1966.
28.
Hirsh, J., et al:  Hypofibrinogenemia Without Increased Fibrinolysis in Leukemia ,  Lancet 1:418-420 ( (Feb) ) 1967.Crossref
29.
Baker, W.G., et al:  Hypofibrinogenemic Hemorrhage in Acute Myelogenous Leukemia Treated With Heparin ,  Ann Intern Med 61:116-123 ( (July) ) 1964.Crossref
30.
Brecher, G., and Cronkite, E.P.: " Estimation of the Number of Platelets by Phase Microscopy ,"  The Coagulation of Blood, Methods of Study , New York: Grune & Stratton, Inc., 1955, p 41.
31.
Quick, A.J.:  Hemorrhagic Diseases , Philadelphia: Lea & Febiger, Publishers, 1957.
32.
Owren, P.A., and Aas, K.:  The Control of Dicumarol Therapy and the Quantitative Measurement of Prothrombin and Proconvertin ,  Scand J Clin Lab Invest 3:201-208 ( (July-Sept) ) 1951.Crossref
33.
Borchgrevink, C.F.; Pool, J.G.; and Stormorken, H.:  A New Assay for Factor V (Proaccelerin-Accelerin) Using Russell's Viper Venom ,  J Lab Clin Med 55:625-632 ( (April) ) 1960.
34.
Pool, G.I., and Robinson, J.:  Assay of Plasma AHF ,  Brit J Haemat 5 (suppl 1):17-23 ( (Jan) ) 1959.Crossref
35.
Deykin, D.S., and Wessler, S.:  Activation Product, Factor IX Serum Thrombotic Accelerator Activity and Serum-Induced Thrombosis ,  J Clin Invest 43:160-161 ( (Feb) ) 1964.Crossref
36.
Sise, H.S.; Lavelle, S.M.; and Becker, R.:  Method for Assay of Stuart Factor ,  Proc Soc Exper Biol Med 96:662-664 ( (Dec) ) 1957.Crossref
37.
Horowitz, H.I., et al:  Assay of Plasma Thromboplastin Antecedent (PTA) With Artificially Depleted Normal Plasma ,  Blood 22:35-43 ( (July) ) 1963.
38.
Langdell, R.D.; Wagner, R.H.; and Brinkhous, K.M.:  Effect of Antihemophilic Factor on One-Stage Clotting Tests ,  J Lab Clin Med 41:637-647 ( (April) ) 1953.
39.
Milstone, H.:  Factor in Normal Human Blood Which Participate in Streptococcal Fibrinolysis ,  J Immunol 42:109-116 ( (Oct) ) 1941.
40.
Sherry, S., et al:  Studies on Enhanced Fibrinolytic Activity in Man ,  J Clin Invest 38: 810-822 ( (May) ) 1959.Crossref
41.
Thompson, I.; Hall, T.C.; and Moloney, W.C.:  Combination Therapy of Adult Myelogenous Leukemia: Experience With Simultaneous Use of Vincristine, Amethopterin, 6-Mercaptopurine and Prednisone ,  N Eng J Med 273:1302-1307 ( (Dec 9) ) 1965.Crossref
42.
Burchenal, J.H., and Murphy, M.L.:  Long-Term Survivors in Acute Leukemia ,  Cancer Res 25: 1491-1494 ( (Oct) ) 1965.
43.
Farkass, E.:  Nach Strahlenbehandlung auf Getreten, mit Hamolyse und Defibrinations-Syndrom komplizierte chronische lymphatische Leukamie ,  Z Ges Inn Med 17:597-599 ( (July) ) 1962.
44.
Brown, R.C.; Campbell, D.C.; and Thompson, J.H.:  Increased Fibrinolysin With Malignant Disease ,  Arch Intern Med 109:201-204 ( (Feb) ) 1962.Crossref
45.
Popps, C., and Enache, F.:  Uber einen ungewöhnlichen Fall von fibrinolyse leukozytaren Ursprungs ,  Folia Haemat 84:70-83 ( (Jan-March) ) 1965.
46.
Cattan, A., et al:  Syndrome fibrinopenique au cours de leucemies monoblastiques aigues. Pourvoir fibrinolytique des monoblastes ,  Rev Franc Stud Clin Biol 10:617-624 ( (June-July) ) 1965.
47.
Bernard, J., and Boiron, M.:  Les leucemies à promyelocytes ,  Rev Franc Hemat 4:11-14 ( (Jan-Feb) ) 1964.
48.
Rodriguez-Erdmann, F.:  Bleeding Due to Increased Intravascular Blood Coagulation ,  N Eng J Med 273:1370-1378 ( (Dec 16) ) 1965.Crossref
49.
Sherry, S.:  Fibrinolysis and Afibrinogenemia ,  Anesthesiology 27:465-474 ( (July-Aug) ) 1965.Crossref
50.
Page, E.W.; Fulton, F.D.; and  Glendening, M.B.: The Cause of the Blood Coagulation Defect Following Abruptio Placenta ,  Amer J Obstet Gyec 61:1116-1122 ( (May) ) 1951.
51.
Stafford, J.L.:  The Fibrinolytic Mechanism in Haemostasis: A Review ,  J Clin Path 17:520-530 ( (Sept) ) 1964.Crossref
52.
Fletcher, A.P.; Alkjaersig, N.; and Sherry, S.:  Pathogenesis of the Coagulation Defect Developing During Pathological Plasma Proteolytic ("Fibrinolytic") States: I. The significance of Fibrinogen Proteolysis and Circulating Fibrinogen Breakdown Products ,  J Clin Invest 41:896-916 ( (Nov 4) ) 1962.Crossref
53.
Triantaphyllopoulos, D.C.:  Enzymatic Effects of Fibrinolysis ,  Fed Proc 24:800-803 ( (July-Aug) ) 1965.
54.
Triantaphyllopoulos, E., and Triantaphyllopoulos, D.C.:  Evidence of Antithrombin Activity of the Anticoagulant Fraction of Incubated Fibrinogen ,  Brit J Haematol 11:331-341 ( (May) ) 1965.Crossref
55.
Alkjaersig, N.; Fletcher, A.P.; and Sherry, S.:  Pathogenesis of the Coagulation Defect Developing During Pathological Plasma Proteolytic ("Fibrinolytic") States: II. The Significance, Mechanism and Consequences of Defective Fibrin Polymerization ,  J Clin Invest 41:917-934 ( (Nov 4) ) 1962.Crossref
56.
Niewiarowski, S.; Latallo, Z.; and Stachurska, J.:  Apparition d'un inhibiteur de la thromboplastino-formation au cours de la proteolyse du fibrinogene ,  Rev Hemat 14:118-128 ( (Jan-March) ) 1959.
57.
Kowalski, E.; Kopec, M.; and Wegrzynowicz, Z.:  Influence of Fibrinogen Degradation Products (FDP) on Platelet Aggregation, Adhesiveness, and Viscous Metamorphosis ,  Thromb Diath Haemorrh 10:406-423 ( (Jan) ) 1964.
58.
Hirsh, J.; Fletcher, A.P.; and Sherry, S.:  Effect of Fibrin and Fibrinogen Proteolysis Products on Clot Physical Properties ,  Amer J Physiol 209: 415-424 ( (Aug) ) 1965.
59.
Merskey, C., et al:  Pathogenesis of Fibrinolysis in Defibrination Syndrome: Effect of Heparin Administration ,  Blood 24:701-715 ( (Dec) ) 1964.
60.
Nilehn, J.E., and Nilsson, I.M.:  Demonstration of Fibrinolytic Split Products in Human Sera by an Immunological Method in Spontaneous and Induced Fibrinolytic States ,  Scand J Hemat 1:313-330 ( (Dec) ) 1964.Crossref
61.
Barnhart, M.I., and Riddle, J.M.:  Cellular Localization of Profibrinolysin (Plasminogen) ,  Blood 21:306-321 ( (March) ) 1963.
62.
Gans, H.:  Fibrinolytic Properties of Proteases Derived From Human, Dog and Rabbit Leukocytes ,  Thromb Diath Haemorrh 10:379-389 ( (Jan) ) 1964.
×